ASMB
Assembly Biosciences
–
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 545.72M; Volume: 45.96K; AvgVol 3m: 229.07K; Beta: 1.21;
Cost estimate:
P/E: –; EPS: -2.51; EPS growth quarter/prev quarter: 127.10%;
EPS growth this year: 6.60%; EPS growth past 5 years: -1.80%;
EPS ttm: -2.51;
P/S: 10.64; P/B: 2.15; P/Cashflow: 2.46; P/FCF: ;
Sales: 52.46M; Sales growth quarter/prev quarter: 1178.40%; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -24.40%; ROE – return on equity: -30.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.60%; Insider Transactions:-5.56%;
Institutional Ownership: 93.50%; Institutional Transactions: 3.71%;
Data update: 07/10/2020.